Online citations, reference lists, and bibliographies.

Pleural Resection And Pleural Infusion Chemotherapy For Therapy Of Malignant Pleural Mesothelioma.

J. Zhang, Q. Zhang, W. Zhao, J. Duan, T. Huang
Published 2014 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The aim of this study was to evaluate effective treatment methods of malignant pleural mesothelioma (MPM). Twenty-three patients with MPM were cured by pleural infusion chemotherapy after surgery. Median survival time and the 1-, 2-, and 3-year survival rates were analyzed on the basis of follow-up. Median survival time of all patients was 15 months (range: 3 to 89 months); the 1-, 2-, and 3-year survival rates were 69.6, 43.5, and 13.0%, respectively. The 1-year survival rates of patients in stages I, II, and III were 83.3, 62.5, and 33.3%, respectively, the 2-year survival rates were 50, 37.5, and 33.3%, respectively, and the 3-year survival rates were 34, 23, and 0%, respectively. Surgery-oriented comprehensive treatment was adopted for MPM, which could improve the prognosis and life quality of patients to some extent.
This paper references
10.1016/S0003-4975(96)01228-3
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
Surgical therapy for malignant pleural mesothelioma
Chen Wen-hu (2002)
10.1007/BF02306613
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
10.1593/NEO.06148
p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
S. Hopkins-Donaldson (2006)
p53-induced apoptosis
ヴォーゲルスタイン,バート (1998)
10.1053/j.semtcvs.2009.06.009
Radiation therapy options for malignant pleural mesothelioma.
Elizabeth H. Baldini (2009)
10.1001/archsurg.1983.01390060092027
Cancer: Principles and Practice of Oncology
G. Steele (1983)
Thorac. Cardiovasc. Surg
decortication. Semin (2005)
10.1007/s11864-008-0067-z
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
H. Yang (2008)
10.1097/00000421-199002000-00002
The Treatment of Malignant Mesothelioma of the Pleura: Review of a 5‐Year Experience, With Special Reference to Radiotherapy
D. Ball (1990)
Phase III study of pemetrexed in combination
NJ Vogelzang (2003)
10.1053/j.semtcvs.2009.06.011
Current trends in radiologic management of malignant pleural mesothelioma.
Ritu R Gill (2009)
10.1200/JCO.1983.1.11.695
Malignant mesothelioma following radiation exposure.
K. H. Antman (1983)
10.1016/j.crad.2009.03.010
CT appearances of pleural tumours.
H. Salahudeen (2009)
10.1634/THEONCOLOGIST.6-4-363
Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors.
A. Hanauske (2001)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
multiple solid tumors
R Hassan (2008)
10.1053/j.semtcvs.2009.06.008
Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
Raja M Flores (2009)
10.1007/s11864-008-0070-4
Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma
M. Kent (2008)
10.1634/THEONCOLOGIST.9-5-482
FDA drug approval summaries: pemetrexed (Alimta).
M. Hazarika (2004)
10.1007/s002680020021
Treatment of Malignant Mesothelioma
M. D. Michael T. Jaklitsch (2001)
10.1007/s00104-016-0186-1
[Surgical therapy of malignant pleural mesothelioma].
Moritz Schirren (2016)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
JR Testa (2008)
p 53induced apoptosis occurs in the absence of p 14 ( ARF ) in malignant pleural mesothelioma
MT Jaklitsch (2006)
10.1038/ncponc0839
Malignant pleural mesothelioma: current concepts in treatment
A. Tsiouris (2007)
10.1165/rcmb.2010-0026RT
Gene therapy for mesothelioma and lung cancer.
A. Vachani (2010)
Medical thoracoscopy for diagnosis and treatment of pleural mesothelioma
Li Jing (2005)
10.1007/978-1-4615-1589-0_13
Malignant pleural mesothelioma.
L. Ho (2001)
10.1016/J.EJCA.2007.08.028
Mesothelin targeted cancer immunotherapy.
R. Hassan (2008)
10.1007/S002680020021
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
10.1007/978-3-642-10862-4
[Malignant mesothelioma].
J. Espinosa Arranz (1994)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar